
Vip Patel
Examiner (ID: 11268, Phone: (571)272-2458 , Office: P/2879 )
| Most Active Art Unit | 2879 |
| Art Unit(s) | 2215, 3621, 2889, 2604, 2875, 2618, 2879 |
| Total Applications | 2443 |
| Issued Applications | 2199 |
| Pending Applications | 38 |
| Abandoned Applications | 210 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4045697
[patent_doc_number] => 05968738
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-19
[patent_title] => 'Two-reporter FACS analysis of mammalian cells using green fluorescent proteins'
[patent_app_type] => 1
[patent_app_number] => 8/761771
[patent_app_country] => US
[patent_app_date] => 1996-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 6024
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/968/05968738.pdf
[firstpage_image] =>[orig_patent_app_number] => 761771
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/761771 | Two-reporter FACS analysis of mammalian cells using green fluorescent proteins | Dec 5, 1996 | Issued |
Array
(
[id] => 3923567
[patent_doc_number] => 05952171
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-14
[patent_title] => 'Method for identifying genes encoding secreted or membrane-associated proteins'
[patent_app_type] => 1
[patent_app_number] => 8/752307
[patent_app_country] => US
[patent_app_date] => 1996-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 6
[patent_no_of_words] => 10488
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/952/05952171.pdf
[firstpage_image] =>[orig_patent_app_number] => 752307
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/752307 | Method for identifying genes encoding secreted or membrane-associated proteins | Nov 18, 1996 | Issued |
Array
(
[id] => 4180672
[patent_doc_number] => 06020202
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-01
[patent_title] => 'Composition and methods for transfecting eukaryotic cells'
[patent_app_type] => 1
[patent_app_number] => 8/746896
[patent_app_country] => US
[patent_app_date] => 1996-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10675
[patent_no_of_claims] => 97
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/020/06020202.pdf
[firstpage_image] =>[orig_patent_app_number] => 746896
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/746896 | Composition and methods for transfecting eukaryotic cells | Nov 17, 1996 | Issued |
Array
(
[id] => 3768218
[patent_doc_number] => 05849580
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Nucleic acid encoding a NF-.kappa.B activation regulatory protein, I.kappa.B.beta.'
[patent_app_type] => 1
[patent_app_number] => 8/748428
[patent_app_country] => US
[patent_app_date] => 1996-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 18750
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849580.pdf
[firstpage_image] =>[orig_patent_app_number] => 748428
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/748428 | Nucleic acid encoding a NF-.kappa.B activation regulatory protein, I.kappa.B.beta. | Nov 12, 1996 | Issued |
Array
(
[id] => 3986253
[patent_doc_number] => 05959094
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'p75 TNF receptor promoters'
[patent_app_type] => 1
[patent_app_number] => 8/737371
[patent_app_country] => US
[patent_app_date] => 1996-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12865
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/959/05959094.pdf
[firstpage_image] =>[orig_patent_app_number] => 737371
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/737371 | p75 TNF receptor promoters | Nov 11, 1996 | Issued |
Array
(
[id] => 1065390
[patent_doc_number] => 06846624
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-25
[patent_title] => 'Expression cloning process for gene coding for a zinc-binding protein'
[patent_app_type] => utility
[patent_app_number] => 09/068461
[patent_app_country] => US
[patent_app_date] => 1996-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2559
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/846/06846624.pdf
[firstpage_image] =>[orig_patent_app_number] => 09068461
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/068461 | Expression cloning process for gene coding for a zinc-binding protein | Nov 4, 1996 | Issued |
Array
(
[id] => 3981926
[patent_doc_number] => 05861278
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'HNF3.delta. compositions'
[patent_app_type] => 1
[patent_app_number] => 8/742753
[patent_app_country] => US
[patent_app_date] => 1996-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9731
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861278.pdf
[firstpage_image] =>[orig_patent_app_number] => 742753
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/742753 | HNF3.delta. compositions | Oct 31, 1996 | Issued |
Array
(
[id] => 1477896
[patent_doc_number] => 06344445
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-05
[patent_title] => 'Herpes virus vectors and their uses'
[patent_app_type] => B1
[patent_app_number] => 08/734054
[patent_app_country] => US
[patent_app_date] => 1996-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16033
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/344/06344445.pdf
[firstpage_image] =>[orig_patent_app_number] => 08734054
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/734054 | Herpes virus vectors and their uses | Oct 17, 1996 | Issued |
Array
(
[id] => 3813522
[patent_doc_number] => 05770374
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-23
[patent_title] => 'Methods for identifying oncogenes and anti-oncogenes'
[patent_app_type] => 1
[patent_app_number] => 8/728608
[patent_app_country] => US
[patent_app_date] => 1996-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 13238
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/770/05770374.pdf
[firstpage_image] =>[orig_patent_app_number] => 728608
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/728608 | Methods for identifying oncogenes and anti-oncogenes | Oct 9, 1996 | Issued |
Array
(
[id] => 4236272
[patent_doc_number] => 06090618
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-18
[patent_title] => 'DNA constructs and viral vectors comprising a smooth muscle promoter'
[patent_app_type] => 1
[patent_app_number] => 8/726807
[patent_app_country] => US
[patent_app_date] => 1996-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 37566
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/090/06090618.pdf
[firstpage_image] =>[orig_patent_app_number] => 726807
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/726807 | DNA constructs and viral vectors comprising a smooth muscle promoter | Oct 6, 1996 | Issued |
Array
(
[id] => 3759261
[patent_doc_number] => 05851827
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-22
[patent_title] => 'DNA encoding clostridium perfringens alpha-toxin peptides'
[patent_app_type] => 1
[patent_app_number] => 8/725518
[patent_app_country] => US
[patent_app_date] => 1996-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 5052
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/851/05851827.pdf
[firstpage_image] =>[orig_patent_app_number] => 725518
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/725518 | DNA encoding clostridium perfringens alpha-toxin peptides | Oct 3, 1996 | Issued |
Array
(
[id] => 4006075
[patent_doc_number] => 05859199
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Transcription factor DP-3 and isoforms thereof'
[patent_app_type] => 1
[patent_app_number] => 8/723415
[patent_app_country] => US
[patent_app_date] => 1996-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 18183
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/859/05859199.pdf
[firstpage_image] =>[orig_patent_app_number] => 723415
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/723415 | Transcription factor DP-3 and isoforms thereof | Sep 29, 1996 | Issued |
Array
(
[id] => 3791095
[patent_doc_number] => 05726043
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-10
[patent_title] => 'Process for the production of protease inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/715252
[patent_app_country] => US
[patent_app_date] => 1996-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15670
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/726/05726043.pdf
[firstpage_image] =>[orig_patent_app_number] => 715252
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/715252 | Process for the production of protease inhibitors | Sep 15, 1996 | Issued |
Array
(
[id] => 4044225
[patent_doc_number] => 05912168
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'CD95 regulatory gene sequences'
[patent_app_type] => 1
[patent_app_number] => 8/713557
[patent_app_country] => US
[patent_app_date] => 1996-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 10549
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/912/05912168.pdf
[firstpage_image] =>[orig_patent_app_number] => 713557
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/713557 | CD95 regulatory gene sequences | Aug 29, 1996 | Issued |
Array
(
[id] => 3773200
[patent_doc_number] => 05817501
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-06
[patent_title] => 'DNA encoding suppressin protein and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/696349
[patent_app_country] => US
[patent_app_date] => 1996-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8218
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/817/05817501.pdf
[firstpage_image] =>[orig_patent_app_number] => 696349
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/696349 | DNA encoding suppressin protein and uses thereof | Aug 12, 1996 | Issued |
Array
(
[id] => 1531163
[patent_doc_number] => 06410033
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Recombinant infectious bovine rhinotracheitis virus'
[patent_app_type] => B1
[patent_app_number] => 08/379647
[patent_app_country] => US
[patent_app_date] => 1996-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 93
[patent_no_of_words] => 44017
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410033.pdf
[firstpage_image] =>[orig_patent_app_number] => 08379647
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/379647 | Recombinant infectious bovine rhinotracheitis virus | Aug 4, 1996 | Issued |
Array
(
[id] => 3807058
[patent_doc_number] => 05811272
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-22
[patent_title] => 'Method for controlling molecular weight of polyhydroxyalkanoates'
[patent_app_type] => 1
[patent_app_number] => 8/687806
[patent_app_country] => US
[patent_app_date] => 1996-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 6124
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/811/05811272.pdf
[firstpage_image] =>[orig_patent_app_number] => 687806
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/687806 | Method for controlling molecular weight of polyhydroxyalkanoates | Jul 25, 1996 | Issued |
Array
(
[id] => 3692051
[patent_doc_number] => 05679525
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-21
[patent_title] => 'Epstein-barr virus transcription factor binding assay'
[patent_app_type] => 1
[patent_app_number] => 8/704398
[patent_app_country] => US
[patent_app_date] => 1996-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7606
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/679/05679525.pdf
[firstpage_image] =>[orig_patent_app_number] => 704398
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/704398 | Epstein-barr virus transcription factor binding assay | Jul 16, 1996 | Issued |
Array
(
[id] => 3875624
[patent_doc_number] => 05804372
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Method of distinguishing an IBRV-vaccinated bovine from a bovine infected with a wild type virus'
[patent_app_type] => 1
[patent_app_number] => 8/674169
[patent_app_country] => US
[patent_app_date] => 1996-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 48
[patent_no_of_words] => 29017
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804372.pdf
[firstpage_image] =>[orig_patent_app_number] => 674169
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/674169 | Method of distinguishing an IBRV-vaccinated bovine from a bovine infected with a wild type virus | Jun 30, 1996 | Issued |
Array
(
[id] => 3887313
[patent_doc_number] => 05834236
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'AATT repeat transcription enhancer element'
[patent_app_type] => 1
[patent_app_number] => 8/669721
[patent_app_country] => US
[patent_app_date] => 1996-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 12663
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/834/05834236.pdf
[firstpage_image] =>[orig_patent_app_number] => 669721
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/669721 | AATT repeat transcription enhancer element | Jun 26, 1996 | Issued |